Ditazole
Chemical compound
- B01AC01 (WHO)
- 2,2'-(4,5-Diphenyloxazol-2-ylazanediyl)diethanol
- 18471-20-0 Y
- 29088
- DB08994 N
- 27061 N
- H2BQI5Z8FT
- D07138 Y
- DTXSID3022954
- Interactive image
- C1=CC=C(C=C1)C2=C(OC(=N2)N(CCO)CCO)C3=CC=CC=C3
InChI
- InChI=1S/C19H20N2O3/c22-13-11-21(12-14-23)19-20-17(15-7-3-1-4-8-15)18(24-19)16-9-5-2-6-10-16/h1-10,22-23H,11-14H2 N
- Key:UUCMDZWCRNZCOY-UHFFFAOYSA-N N
Ditazole is a non-steroidal anti-inflammatory agent with analgesic and antipyretic activity similar to phenylbutazone.[1] It is also a platelet aggregation inhibitor which is marketed in Spain and Portugal under the trade name Ageroplas.[2]
References
- v
- t
- e
Glycoprotein IIb/IIIa inhibitors |
|
---|---|
ADP receptor/P2Y12 inhibitors | |
Prostaglandin analogue (PGI2) | |
COX inhibitors | |
Thromboxane inhibitors | |
Phosphodiesterase inhibitors | |
Other |
|
Vitamin K antagonists (inhibit II, VII, IX, X) | |||||
---|---|---|---|---|---|
Factor Xa inhibitors (with some II inhibition) |
| ||||
Direct thrombin (IIa) inhibitors |
| ||||
Other |
fibrinolytics
- #WHO-EM
- ‡Withdrawn from market
- Clinical trials:
- †Phase III
- §Never to phase III
This drug article relating to the blood and blood forming organs is a stub. You can help Wikipedia by expanding it. |
- v
- t
- e